Clinical Trial Detail

NCT ID NCT02793544
Title HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Center for International Blood and Marrow Transplant Research
Indications

myelodysplastic syndrome

acute leukemia

lymphoma

lymphoblastic lymphoma

chronic lymphocytic leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Cyclophosphamide

Busulfan

Sirolimus

Mycophenolate mofetil

Mesna

Fludarabine

Age Groups: adult child senior

No variant requirements are available.